Evidence map›Paper›PMID 32540735›Full record

ReviewDiabetes & metabolic syndrome

COVID-19 and addiction.

Mahua Jana Dubey, Ritwik Ghosh, Subham Chatterjee, Payel Biswas, Subhankar Chatterjee, Souvik Dubey

Abstract readReview
In one paragraph

Review in Diabetes & metabolic syndrome. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 178 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
178citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

178 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

118 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mahua Jana DubeyDepartment of Psychiatry, Specialist Medical Officer, Department of Psychiatry, Berhampore Mental Hospital, Berhampore, Mushridabad, West Bengal, India. Electronic address: drmjdpsy03@gmail.com.
Ritwik GhoshDepartment of General Medicine, Burdwan Medical College and Hospital, Burdwan, West Bengal, India. Electronic address: ritwikmed2014@gmail.com.
Subham ChatterjeeDepartment of Psychiatry, Institute of Psychiatry, Institute of Post Graduate Medical Education and Research & SSKM Hospital, Kolkata, West Bengal, India. Electronic address: subham171293@gmail.com.
Payel BiswasDepartment of Radiodiagnosis, Care & Cure Hospital, Barasat, West Bengal, India. Electronic address: itiranisarkar@gmail.com.
Subhankar ChatterjeeDepartment of General Medicine, Department of General Medicine, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand, India. Electronic address: chatterjeeaspiresubhankar.92@gmail.com.
Souvik DubeyDepartment of Neuromedicine, Bangur Institute of Neurosciences, Institute of Post Graduate Medical Education and Research & SSKM Hospital, Kolkata, West Bengal, India. Electronic address: drsouvik79@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

aims2019-coronavirus disease (COVID-19) is causing insurmountable psychosocial impact on the whole mankind. Marginalized community, particularly those with substance use disorders (SUD), are particularly vulnerable to contract the infection and also likely to suffer from greater psychosocial burden. This article analyses the intricate bi-directional relationship between COVID-19 and addiction.

methodsPubmed and Google Scholar are searched with the following key terms- "COVID-19", "SARS-CoV2", "Pandemic", "Addiction", "Opioid", "Alcohol", "Smoking", "Addiction Psychiatry", "Deaddiction", "Substance use disorders", "Behavioral addiction". Few newspaper reports related to COVID-19 and addiction have also been added as per context.

resultsPeople with SUD are at greater risk of worse COVID-19 outcome. There is surge of addictive behaviors (both new and relapse) including behavioral addiction in this period. Withdrawal emergencies and death are also being increasingly reported. Addicted people are especially facing difficulties in accessing the healthcare services which are making them prone to procure drugs by illegal means.

conclusionCOVID-19 and addiction are the two pandemics which are on the verge of collision causing major public health threat. While every effort must be taken to make the public aware of deleterious effects of SUD on COVID-19 prognosis, the resumption of deaddiction services and easier accessibility of prescription drugs are needs of the hour.

Indexed as

Behavior, AddictiveBetacoronavirusCoronavirus InfectionsCOVID-19Delivery of Health CareHealth Services AccessibilityHumansPandemicsPneumonia, ViralPrognosisSARS-CoV-2Social MarginalizationSubstance-Related DisordersAddictionAlcoholBehavioral addictionCOVID-19InternetOpioidPandemicSARS-CoV2Smoking

Identifiers

PMID32540735
PMCPMC7282772

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.